Literature DB >> 8947923

Laminar distribution of the multiple opioid receptors in the human cerebral cortex.

J M Hiller1, L Q Fan.   

Abstract

Quantitative autoradiographic assessment of cerebral cortical laminar distribution of mu, delta and kappa opioid receptors was carried out in coronal sections of five post-mortem human brains obtained at autopsy. The cortical areas studied were: cingulate, frontal, insular, parietal, parahippocampal, temporal, occipitotemporal, occipital and striate area. In general, the laminar patterns of distribution for the three types of receptors are distinctive. Peak levels of delta opioid binding are in laminae I, II, and IIIa. mu-Receptors are located in lamina III followed by I and II in cingulate, frontal, insular and parietal cortices and lamina IV in temporal and occiptotemporal cortices. kappa-Receptors are found concentrated in laminae V and VI. The patterns of opioid binding in cortical laminae showed remarkable consistency in all five brains examined. In contrast to other cortical areas, the parahippocampal gyrus, at the level of the amygdaloid formation, demonstrated peak kappa receptor density in laminae I, II and III. mu-Opioid binding was undetectable in the lateral occipital cortex and in the striate area.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947923     DOI: 10.1007/bf02532374

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  58 in total

1.  Regionally selective increases in mu opioid receptor density in the brains of suicide victims.

Authors:  R Gross-Isseroff; K A Dillon; M Israeli; A Biegon
Journal:  Brain Res       Date:  1990-10-22       Impact factor: 3.252

2.  Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients.

Authors:  J M Hiller; Y Itzhak; E J Simon
Journal:  Brain Res       Date:  1987-03-17       Impact factor: 3.252

3.  Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects.

Authors:  P Delay-Goyet; J M Zajac; F Javoy-Agid; Y Agid; B P Roques
Journal:  Brain Res       Date:  1987-06-23       Impact factor: 3.252

4.  Adult and developing human cerebella exhibit different profiles of opioid binding sites.

Authors:  I S Zagon; D M Gibo; P J McLaughlin
Journal:  Brain Res       Date:  1990-07-16       Impact factor: 3.252

5.  Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.

Authors:  K Jhamandas; M Sutak
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

6.  The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.

Authors:  F Simonin; K Befort; C Gavériaux-Ruff; H Matthes; V Nappey; B Lannes; G Micheletti; B Kieffer
Journal:  Mol Pharmacol       Date:  1994-12       Impact factor: 4.436

7.  The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C.

Authors:  A Mestek; J H Hurley; L S Bye; A D Campbell; Y Chen; M Tian; J Liu; H Schulman; L Yu
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

8.  Quantitative light microscopic autoradiographic localization of alpha 2-adrenoceptors in the human brain.

Authors:  J Pascual; C del Arco; A M González; A Pazos
Journal:  Brain Res       Date:  1992-07-10       Impact factor: 3.252

9.  Multiple opiate receptor in human brain: an autoradiographic investigation.

Authors:  R Maurer; R Cortés; A Probst; J M Palacios
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

10.  Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices.

Authors:  H F Bradford; J M Crowder; E J White
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

View more
  19 in total

1.  Electroencephalographic and convulsant effects of the delta opioid agonist SNC80 in rhesus monkeys.

Authors:  Ingela Danielsson; Maciej Gasior; Glenn W Stevenson; John E Folk; Kenner C Rice; S Stevens Negus
Journal:  Pharmacol Biochem Behav       Date:  2006-11-15       Impact factor: 3.533

2.  An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989.

Authors:  Ming-Qiang Zheng; Su Jin Kim; Daniel Holden; Shu-fei Lin; Anne Need; Karen Rash; Vanessa Barth; Charles Mitch; Antonio Navarro; Michael Kapinos; Kathleen Maloney; Jim Ropchan; Richard E Carson; Yiyun Huang
Journal:  J Nucl Med       Date:  2014-05-22       Impact factor: 10.057

3.  μ and κ opioid receptor distribution in the monogamous titi monkey (Callicebus cupreus): implications for social behavior and endocrine functioning.

Authors:  B J Ragen; S M Freeman; S A Laredo; S P Mendoza; K L Bales
Journal:  Neuroscience       Date:  2015-01-29       Impact factor: 3.590

4.  Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.

Authors:  Songye Li; Ming-Qiang Zheng; Mika Naganawa; Sujin Kim; Hong Gao; Michael Kapinos; David Labaree; Yiyun Huang
Journal:  J Nucl Med       Date:  2019-01-10       Impact factor: 10.057

Review 5.  Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.

Authors:  Xiaozhou He; Harleen K Sandhu; Yilin Yang; Fei Hua; Nathalee Belser; Dong H Kim; Ying Xia
Journal:  Cell Mol Life Sci       Date:  2012-09-27       Impact factor: 9.261

6.  Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.

Authors:  Michael S Placzek; Genevieve C Van de Bittner; Hsiao-Ying Wey; Scott E Lukas; Jacob M Hooker
Journal:  Neuropsychopharmacology       Date:  2015-06-10       Impact factor: 7.853

7.  Feeding Releases Endogenous Opioids in Humans.

Authors:  Jetro J Tuulari; Lauri Tuominen; Femke E de Boer; Jussi Hirvonen; Semi Helin; Pirjo Nuutila; Lauri Nummenmaa
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

Review 8.  Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.

Authors:  Christopher R Bailey; Elisabeth Cordell; Sean M Sobin; Alexander Neumeister
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

9.  Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.

Authors:  Ming-Qiang Zheng; Nabeel Nabulsi; Su Jin Kim; Giampaolo Tomasi; Shu-Fei Lin; Charles Mitch; Steven Quimby; Vanessa Barth; Karen Rash; John Masters; Antonio Navarro; Eric Seest; Evan D Morris; Richard E Carson; Yiyun Huang
Journal:  J Nucl Med       Date:  2013-01-25       Impact factor: 10.057

Review 10.  [Positron emission tomography in pain research. From the structure to the activity of the opiate receptor system].

Authors:  T Sprenger; G Henriksen; M Valet; S Platzer; A Berthele; T R Tölle
Journal:  Schmerz       Date:  2007-11       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.